{"id":740077,"date":"2023-03-14T16:42:35","date_gmt":"2023-03-14T20:42:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/"},"modified":"2023-03-14T16:42:35","modified_gmt":"2023-03-14T20:42:35","slug":"vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/","title":{"rendered":"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023"},"content":{"rendered":"
\n

PALO ALTO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced\u00a0four poster presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held virtually and at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023.<\/p>\n

\n Poster presentation details:<\/strong>\u00a0<\/p>\n\n\n\n\n\n\n\n\n
\n Poster Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nVIP236: A small molecule drug conjugate with an optimized camptothecin payload has significant activity in patient-derived and metastatic cancer models<\/td>\n<\/tr>\n
\n Abstract Number:<\/strong>\n <\/td>\n\u00a0<\/td>\n484<\/td>\n<\/tr>\n
\n Presenter:<\/strong>\n <\/td>\n\u00a0<\/td>\nBeatrix Stelte-Ludwig, PhD<\/td>\n<\/tr>\n
\n Session Type:<\/strong>\n <\/td>\n\u00a0<\/td>\nIn-Person Poster Presentation<\/td>\n<\/tr>\n
\n Session Title:\u00a0<\/strong>\n <\/td>\n\u00a0<\/td>\nNovel Antitumor Agents 1<\/td>\n<\/tr>\n
\n Session Time:<\/strong>\n <\/td>\n\u00a0<\/td>\nSunday, April 16, 2023 at 1:30 PM ET<\/td>\n<\/tr>\n
\n Location:<\/strong>\n <\/td>\n\u00a0<\/td>\nPoster Section 17; Poster Board Number 15<\/td>\n<\/tr>\n<\/table>\n

\n \n <\/p>\n\n\n\n\n\n\n\n\n
\n Poster Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nTargeting CDK9 via the small-molecule inhibitor enitociclib as a therapeutic strategy to treat\u00a0MYCN<\/em>-amplified rhabdomyosarcoma and neuroblastoma in children<\/td>\n<\/tr>\n
\n Abstract Number:<\/strong>\n <\/td>\n\u00a0<\/td>\n1558<\/td>\n<\/tr>\n
\n Presenter:\u00a0<\/strong>\n <\/td>\n\u00a0<\/td>\nAndy Tran<\/td>\n<\/tr>\n
\n Session Type:<\/strong>\n <\/td>\n\u00a0<\/td>\nIn-Person Poster Presentation<\/td>\n<\/tr>\n
\n Session Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nCell Cycle\/Cell Proliferation Inhibitors for Cancer Therapy<\/td>\n<\/tr>\n
\n Session Time:<\/strong>\n <\/td>\n\u00a0<\/td>\nMonday, April 17, 2023 at 9:30 AM ET<\/td>\n<\/tr>\n
\n Location:<\/strong>\n <\/td>\n\u00a0<\/td>\nPoster Section 15; Poster Board Number 6<\/td>\n<\/tr>\n<\/table>\n

\n \n <\/p>\n\n\n\n\n\n\n\n\n
\n Poster Title:\u00a0<\/strong>\n <\/td>\n\u00a0<\/td>\nSynthesis and characterization of novel small molecule drug conjugates with different payloads designed to be released in tumor microenvironment by neutrophil elastase<\/td>\n<\/tr>\n
\n Abstract Number:<\/strong>\n <\/td>\n\u00a0<\/td>\n2722<\/td>\n<\/tr>\n
\n Presenter:<\/strong>\n <\/td>\n\u00a0<\/td>\nHans-Georg Lerchen, PhD<\/td>\n<\/tr>\n
\n Session Type:<\/strong>\n <\/td>\n\u00a0<\/td>\nIn-Person Poster Presentation<\/td>\n<\/tr>\n
\n Session Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nDrug Delivery Systems<\/td>\n<\/tr>\n
\n Session Time:<\/strong>\n <\/td>\n\u00a0<\/td>\nMonday, April 17, 2023 at 1:30 PM ET<\/td>\n<\/tr>\n
\n Location:<\/strong>\n <\/td>\n\u00a0<\/td>\nPoster Section 15; Poster Board Number 25<\/td>\n<\/tr>\n<\/table>\n

\n \n <\/p>\n\n\n\n\n\n\n\n\n
\n Poster Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nCXCR5 is a very promising drug target for the development of antibody-drug conjugates to treat patients with lymphoma<\/td>\n<\/tr>\n
\n Abstract Number:<\/strong>\n <\/td>\n\u00a0<\/td>\n6294<\/td>\n<\/tr>\n
\n Presenter:<\/strong>\n <\/td>\n\u00a0<\/td>\nTibor Schomber, PhD<\/td>\n<\/tr>\n
\n Session Type:<\/strong>\n <\/td>\n\u00a0<\/td>\nIn-Person Poster Presentation<\/td>\n<\/tr>\n
\n Session Title:<\/strong>\n <\/td>\n\u00a0<\/td>\nGrowth Factor Receptors as Therapeutic Targets<\/td>\n<\/tr>\n
\n Session Time:<\/strong>\n <\/td>\n\u00a0<\/td>\nWednesday, April 19, 2023 at 9:00 AM ET<\/td>\n<\/tr>\n
\n Location:<\/strong>\n <\/td>\n\u00a0<\/td>\nPoster Section 21; Poster Board Number 1<\/td>\n<\/tr>\n<\/table>\n

\n
A copy of the presentation materials can be accessed on the Investors section of the Company\u2019s website at\u00a0www.vincerx.com<\/a>\u00a0once each presentation has concluded.<\/p>\n

\n About\u00a0Vincerx Pharma, Inc.<\/strong>\n <\/p>\n

Vincerx Pharma, Inc. (Vincerx) is a clinical-stage biopharmaceutical company committed to developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. Vincerx has assembled a seasoned management team with a proven track record of successful oncology drug development, approvals, and value creation. The company\u2019s diverse pipeline consists of enitociclib, currently in Phase 1, and a proprietary modular bioconjugation platform, which includes a small molecule drug-conjugate, VIP236, in Phase 1, and preclinical next-generation antibody drug conjugates, VIP943 and VIP924.<\/p>\n

Vincerx Pharma is based in Palo Alto, Calif., and has a research facility in Monheim, Germany. For more information, please visit www.vincerx.com<\/a>.<\/p>\n

\n Contacts<\/strong>
\n
Bruce Mackle
LifeSci Advisors, LLC
646-889-1200
bmackle@lifesciadvisors.com<\/a><\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PALO ALTO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced\u00a0four poster presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held virtually and at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023. Poster presentation details:\u00a0 Poster Title: \u00a0 VIP236: A small molecule drug conjugate with an optimized camptothecin payload has significant activity in patient-derived and metastatic cancer models Abstract Number: \u00a0 484 Presenter: \u00a0 Beatrix Stelte-Ludwig, PhD Session Type: \u00a0 In-Person Poster Presentation Session Title:\u00a0 \u00a0 Novel Antitumor Agents 1 Session Time: \u00a0 Sunday, April 16, 2023 at 1:30 … <\/p>\n

Continue reading “Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740077","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced\u00a0four poster presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held virtually and at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023. Poster presentation details:\u00a0 Poster Title: \u00a0 VIP236: A small molecule drug conjugate with an optimized camptothecin payload has significant activity in patient-derived and metastatic cancer models Abstract Number: \u00a0 484 Presenter: \u00a0 Beatrix Stelte-Ludwig, PhD Session Type: \u00a0 In-Person Poster Presentation Session Title:\u00a0 \u00a0 Novel Antitumor Agents 1 Session Time: \u00a0 Sunday, April 16, 2023 at 1:30 … Continue reading "Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T20:42:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023\",\"datePublished\":\"2023-03-14T20:42:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/\"},\"wordCount\":436,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/\",\"name\":\"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==\",\"datePublished\":\"2023-03-14T20:42:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/","og_locale":"en_US","og_type":"article","og_title":"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Market Newsdesk","og_description":"PALO ALTO, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC),\u00a0a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced\u00a0four poster presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held virtually and at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023. Poster presentation details:\u00a0 Poster Title: \u00a0 VIP236: A small molecule drug conjugate with an optimized camptothecin payload has significant activity in patient-derived and metastatic cancer models Abstract Number: \u00a0 484 Presenter: \u00a0 Beatrix Stelte-Ludwig, PhD Session Type: \u00a0 In-Person Poster Presentation Session Title:\u00a0 \u00a0 Novel Antitumor Agents 1 Session Time: \u00a0 Sunday, April 16, 2023 at 1:30 … Continue reading \"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-14T20:42:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023","datePublished":"2023-03-14T20:42:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/"},"wordCount":436,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/","name":"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==","datePublished":"2023-03-14T20:42:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1NDI5NCM1NDIyMTE4IzUwMDA3NDU2Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vincerx-pharma-announces-poster-presentations-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740077"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740077\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}